Desogestrel And Ethinyl Estradiol Kit
Product Images NDC 60505-4896

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol (NDC 60505-4896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (Blister)

Blister (Blister)
Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg 28-Day oral tablet kit. The blister pack is labeled for a 28-day regimen with day and week markers. Manufactured by Mankind Pharma Private Limited and labeled for Apotex Corp. Storage instructions and lot/expiration fields are visible. The pack features Apotex Corp branding and a barcode.*
FDA Label Image

Deso-ee-02 (Deso Ee 02)

Deso-ee-02 (Deso Ee 02)
A bar chart displaying mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45 and older). The chart compares four groups: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers), showing higher mortality rates for smokers, particularly in the oldest age group.*
FDA Label Image

Deso-ee-structure (Deso Ee Structure)

Deso-ee-structure (Deso Ee Structure)
Chemical structure diagrams of desogestrel and ethinyl estradiol, the active ingredients in the product. The structures show molecular frameworks with labeled functional groups relevant to each compound.*
FDA Label Image

Fig-2.jpg (Fig 2)

Fig-2.jpg (Fig 2)
A forest plot chart illustrating the risk of breast cancer associated with combined oral contraceptive use. It displays effect estimates (odds ratios/relative risks) from multiple studies with confidence intervals, comparing ever use and current use. The studies are listed on the left, effect estimates plotted with horizontal lines representing confidence intervals in the center, and numerical estimates with confidence intervals on the right. The x-axis ranges from -1.5 to 2 for the effect estimate scale.*
FDA Label Image

Outer-carton (Outer Carton)

Outer-carton (Outer Carton)
Packaging label for desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg in a kit form by Apotex Corp. The box design includes the product name, strength, dosage form, and labeler information. It states Rx only and specifies 3 pouches of 28 tablets each. Additional packaging details such as barcodes and storage instructions are visible.*
FDA Label Image

Table1-part1 (Table1 Part1)

Table1-part1 (Table1 Part1)
A data table presenting the percentage of women experiencing unintended pregnancy during the first year of typical and perfect use of various contraception methods, along with the percentage continuing use at one year in the United States. Methods include chance, spermicides, periodic abstinence, withdrawal, barrier methods, pills, IUDs, sterilization, and others, with specific statistics for each.*
FDA Label Image

Table1-part2 (Table1 Part2)

Table1-part2 (Table1 Part2)
A text panel providing information about emergency contraceptive pills, including effectiveness when initiated within 72 hours after unprotected intercourse, and details on the Lactation Amenorrhea Method (LAM) as a temporary contraception method. The text cites sources, explains pregnancy risk reduction percentages, FDA declarations on emergency contraceptive brands, and outlines conditions for maintaining effective protection against pregnancy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.